Valcyte (Genentech, Inc.)
Welcome to the PulseAid listing for the Valcyte drug offered from Genentech, Inc.. This Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genentech, Inc. |
NON-PROPRIETARY NAME: | valganciclovir hydrochloride |
SUBSTANCE NAME: | VALGANCICLOVIR HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2001-03-29 |
END MARKETING DATE: | 0000-00-00 |
Valcyte HUMAN PRESCRIPTION DRUG Details:
Item Description | Valcyte from Genentech, Inc. |
LABELER NAME: | Genentech, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 450(mg/1) |
START MARKETING DATE: | 2001-03-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0004-0038_56501016-bcc9-49f9-a249-43071c390211 |
PRODUCT NDC: | 0004-0038 |
APPLICATION NUMBER: | NDA021304 |
Other VALGANCICLOVIR HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: